Author
Jiyuan Wu
Recent research
- Engineering & Technology
Abstract The small ionic radius of Cs+ results in a low tolerance factor for CsPbI3 perovskite, which intrinsically triggers its spontaneous phase transition from black phase to yellow phase, severely limiting the power conversion efficiency and long-term stability of CsPbI3 pero...
- Health & Medicine
52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial
BACKGROUND: Ivarmacitinib, an oral JAK1 inhibitor, improved efficacy outcomes versus placebo at Week 16 in a phase 3 trial in patients with moderate-to-severe atopic dermatitis (AD). OBJECTIVES: To describe efficacy and safety outcomes through Week 52. METHODS: In this multicentr...